Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
Tuesday, November 04, 2025Rein Therapeuticsa biopharmaceutical company advancing a novel pipeline of firstinclass medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications today announced that the US Food and Drug Administration
Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer's Disease
Tuesday, November 04, 2025Arctic Therapeutics ATx an Icelandbased clinicalstage biopharmaceutical company today announced key regulatory milestones for its lead investigational therapy AT
Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases
Friday, October 31, 2025Boehringer Ingelheim and Kyowa Kirin Co Ltdtoday announced that Boehringer Ingelheim has licensed a preclinical program from Kyowa Kirin to develop a potential firstinclass small molecule for the treatment of autoimmune diseases
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Thursday, October 30, 2025Thermo Fisher Scientific Inc the world leader in serving science today announced a definitive agreement to acquire Clario Holdings Inc a leading provider of endpoint data solutions for clinical trials
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
Wednesday, October 29, 2025Roche announced today statistically significant and clinically meaningful results from the phase III INShore study of GazyvaGazyvaro obinutuzumab in children and young adults aged years with idiopathic nephrotic syndrome
Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies
Wednesday, October 29, 2025Merck a leading science and technology company has entered into a partnership with Promega Corporation a global life science solutions and service leader based in Madison Wisconsin
Measuring Patient Engagement Summit Europe
Tuesday, October 28, 2025As patient engagement becomes a cornerstone of clinical regulatory and access success Europes life sciences community is preparing to tackle one of its biggest challenges yet how to measure its true impact
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Tuesday, October 28, 2025Amneal Pharmaceuticals Inc today announced the US commercial launch of Brekiya dihydroergotamine mesylate injection the first and only readytouse dihydroergotamine DHE autoinjector approved
Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
Friday, October 24, 2025Halia Therapeutics Inc a clinicalstage biopharmaceutical company pioneering therapies that target the root causes of inflammationdriven diseases today announced that the US Food and Drug Administration FDA
Upperton Expands High Precision Filling Capability at Nottingham Facility
Wednesday, October 22, 2025Upperton a leading contract development and manufacturing organisation CDMO based in Nottingham UK has increased its high precision filling capability with the installation and commission of the FillWeight gravimetric powder filling machine
